We're relying on you to nominate the trailblazing thought leaders, opinion shapers and unsung heroes of pathology that you want to see on the list!
Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?
Variants in the FUT2 gene may increase susceptibility to otitis media by altering the microbiome of the middle ear
The use of saliva as a diagnostic fluid seems an attractive option – especially now that research reveals circulating tumor DNA in the fluid
The FLEX breast cancer registry intends to collect complete information on 10,000 patients over the course of 10 years
George Vasmatzis and John Cheville
Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients
Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care
Lisa M. Wright
To harness liquid biopsy’s many advantages, it’s vital to ensure appropriate testing – and cfDNA synthetic plasma reference standards can help
The spatial arrangement of immune cells could predict whether aggressive chemotherapy is the best option for patients with early-stage lung cancer
An electronic gas-sensing capsule may increase diagnostic and monitoring accuracy in disorders of the digestive tract
Niamh Buckley, Laura Feeney, James Beirne, and Paul Mullan
Markers such as DNA methylation, analyzed by liquid biopsy, may improve on ovarian cancer testing options like gold standard CA125
Send me the latest from The Pathologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.